SC-02

N/A

Report date: 2025/01/26 16:56:27

Base Information

Drug NameSC-02

Drug Alias NamePAN-IgE therapeutics (IGE Therapeutics)anti-C2-3L-GFP vaccine (IGE Therapeutics)IgE modulator (IGE Therapeutics)SC-02

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionImmunoglobulin E modulators

TargetsImmunoglobulin E

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIGE Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesIGE Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsHypersensitivity

Inactive IndicationsN/A

Other Information

ATC CodeN/A